Aventis Pharma Q2 FY11 Results : Net profit rises 7.99%

by khalid on 30/10/2010 · 0 comments

Aventis Pharma Limited has posted a phenomenal increase in net profit for the period Q2 (ending Sep 2010) of the current fiscal (FY11). During the said quarter, net profit rises 7.99% to Rs 47.30 crore in comparison to the Rs 43.80 crore of Q2 (ending Sep 09) of previous year(FY10). ventis Pharma Limited provides medicines for the treatment of patients in several therapeutic areas, such as cardiovascular disease, thrombotic diseases, metabolic disorders, oncology, disorders of the central nervous system, internal medicine
and vaccines.

The company has informed the share market(BSE) that the net sales increased 6.62% to Rs 275.60 crore in quarter ended Sep 2010 when compared with the last years same quarter ended Sep 2009 which was Rs 258.50 crore.

Share’s Data :-
BSE Code : 500674
Mkt. Cap : Rs 4146.90 Crores
Aventis Pharma Ltd. share’s CMP is Rs 1806 on 29th Oct 2010.

Source :- BelltheBull

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: